title: [The new (old) knowledge in primary prevention of stroke. It depends on lowering of blood pressure].
authors.affiliation: Medizinische Univ.-Poliklinik, Wilhelmstr. 35-37, D-53111 Bonn. duesing@uni-bonn.de
authors.forename: R
authors.initials: R
authors.lastname: Düsing
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001741:Black or African American; D017311:Amlodipine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002752:Chlorthalidone / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017292:Doxazosin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D017706:Lisinopril / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control; D011322:Primary Prevention; D020521:Stroke / Q000517:prevention & control*; D013997:Time Factors
chemical_list: D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D017311:Amlodipine; D017706:Lisinopril; D017292:Doxazosin; D002752:Chlorthalidone
vernacular_title: Die neue (alte) Erkenntnis zur Primärprävention des Schlaganfalls: Auf die Blutdrucksenkung kommt es an!